Author: "T. Muranaka" / Journal: annals of oncology - Searchworks@Jio Institute Digital Library Search Results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Your search keyword '"T. Muranaka"' showing total 10 results

Start Over Author "T. Muranaka" Journal annals of oncology

10 results on '"T. Muranaka"'

1. 99P Impact of single-heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma

Author: K. Harada, T. Yamamura, O. Muto, M. Nakamura, S. Sogabe, K. Sawada, S. Nakano, M. Yagisawa, T. Muranaka, M. Dazai, M. Tateyama, Y. Kobayashi, S. Kato, T. Miyagishima, Y. Kawamoto, S. Yuki, Y. Sakata, N. Sakamoto, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2022
Full Text: View/download PDF

2. SO-30 Impact of single-heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma

Author: K. Harada, T. Yamamura, O. Muto, M. Nakamura, S. Sogabe, K. Sawada, S. Nakano, M. Yagisawa, T. Muranaka, M. Dazai, M. Tateyama, K. Ito, R. Saito, Y. Kobayashi, S. Kato, T. Miyagishima, Y. Kawamoto, S. Yuki, Y. Sakata, N. Sakamoto, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2022
Full Text: View/download PDF

3. Multi-centered phase II trial of weekly 5-FU plus l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant advanced gastric cancer (HGCSG1502)

Author: Y. Sasaki, T. Muranaka, Y. Kawamoto, K. Sawada, H. Nakatsumi, K. Harada, T. Miyagishima, K. Hatanaka, M. Dazai, A. Ueda, T. Sasaki, K. Shinada, Y. Tsuji, S. Yuki, N. Sakamoto, N. Nishimoto, Y. Sakata, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2019
Full Text: View/download PDF

4. The comparison between UGT1A1 single heterozygous and wild type regarding the clinical outcomes of fixed dose irinotecan monotherapy for advanced gastric cancer: Multicenter retrospective study

Author: T. Sasaki, S. Nakano, S. Yuki, K. Sawada, T. Muranaka, Y. Kawamoto, H. Nakatsumi, T. Ando, H. Yoshita, K. Harada, Y. Kobayashi, T. Miyagishima, K. Hatanaka, A. Tanimoto, A. Ishiguro, T. Honda, M. Dazai, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2019
Full Text: View/download PDF

5. 172PD Final analysis: Phase II trial of irinotecan/S-1/cetuximab (IRIS/Cet) as second line treatment in patients with KRAS exon2 wild type metastatic colorectal cancer: HGCSG0902. Comparison of administration interval in cetuximab treatment

Author: T. Ando, S. Yuki, H. Nakatsumi, T. Muranaka, A. Hosokawa, Y. Tsuji, M. Nakamura, O. Muto, T. Sasaki, I. Iwanaga, K. Hatanaka, A. Sato, K. Eto, K. Furukawa, M. Tateyama, Y. Takahashi, S. Sogabe, T. Honda, Y. Sakata, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2016
Full Text: View/download PDF

6. The prospective multicenter study of relation between 5-HIAA/substance P plasma concentration transition and nausea/vomiting in patients with gastrointestinal cancer receiving moderately emetogenic chemotherapy (MEC)

Author: K. Sawada, Y. Komatsu, T. Muranaka, S. Nakano, Y. Kawamoto, H. Nakatsumi, S. Yuki, M. Dazai, T. Saiki, A. Ishiguro, M. Tateyama, K. Ono, S. Ohnishi, and N. Sakamoto
Subjects: Oncology, Hematology
Published: 2018
Full Text: View/download PDF

7. HGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer

Author: A. Yoshikawa, Y. Kawamoto, S. Yuki, S. Nakano, K. Sawada, T. Muranaka, H. Nakatsumi, K. Harada, Y. Kobayashi, T. Miyagishima, T. Saiki, A. Ishiguro, R. Saito, N. Ehira, I. Iwanaga, K. Hatanaka, N. Abe, N. Sakamoto, Y. Sakata, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2018
Full Text: View/download PDF

8. HGCSG1301: A multicenter, double-blind, randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment

Author: M. Dazai, S. Yuki, K. Sawada, T. Muranaka, Y. Kawamoto, H. Nakatsumi, S. Nakano, A. Ishiguro, M. Tateyama, A. Sato, Y. Kobayashi, M. Nakamura, H. Okuda, Y. Takahashi, K. Eto, S. Muto, K. Hatanaka, T. Amano, Y. Sakata, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2018
Full Text: View/download PDF

9. HGCSG1401: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer: Analysis of risk factors for liver dysfunction

Author: T. Honda, S. Yuki, T. Muranaka, H. Nakatsumi, Y. Tsuji, T. Miyagishima, S. Yoshida, K. Hatanaka, T. Sasaki, A. Ishiguro, O. Muto, H. Ohnuma, S. Kato, A. Sato, M. Abe, K. Kato, K. Onodera, K. Eto, M. Tateyama, T. Amano, Y. Sakata, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2018
Full Text: View/download PDF

10. HGCSG 1201: Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab

Author: Y. Kawamoto, S. Yuki, T. Meguro, K. Hatanaka, M. Uebayashi, I. Iwanaga, M. Nakamura, K. Eto, H. Okuda, M. Abe, A. Aonuma, N. Abe, A. Sato, H. Nakatsumi, T. Muranaka, M. Yagisawa, K. Oba, Y. Sakata, N. Sakamoto, and Y. Komatsu
Subjects: Oncology, Hematology
Published: 2017
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results